Bio-link Australia Pty. Ltd.

7th January 2015 – Sydney Children’s Hospital Network produce exciting PKU therapeutic proof of principle data

Sydney Children’s Hospital Network have generated exciting in vivo proof of principle data, showing that their GM probiotic significantly limits phenylalanine blood levels in PahENU2 mice (a model of phenylketonuria, PKU), offering the prospect of an efficacious, orally bioavailable probiotic for PKU patients.

SCHN logo